DG

Da-Wei Gong

UB University Of Maryland, Baltimore: 8 patents #31 of 1,115Top 3%
RP Regeneron Pharmaceuticals: 3 patents #320 of 810Top 40%
📍 Olney, MD: #38 of 207 inventorsTop 20%
🗺 Maryland: #4,049 of 35,612 inventorsTop 15%
Overall (All Time): #621,362 of 4,157,543Top 15%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
11713461 Treatment of decreased bone mineral density with zinc and ring finger 3 (ZNRF3) inhibitors Nehal Gosalia, Alan Shuldiner, Cristopher Van Hout, James Perry 2023-08-01
11504390 Treatment of increased lipid levels with sterol regulatory element binding transcription factor 1 (SREBF1) inhibitors Alan Shuldiner, Nehal Gosalia, Cristopher Van Hout, James Perry 2022-11-22
11331332 Treatment of increased lipid levels with sterol regulatory element binding protein cleavage-activating protein (SCAP) inhibitors James Perry, Alan Shuldiner, Nehal Gosalia, Cristopher Van Hout 2022-05-17
10463716 Methods for treating cardiovascular dysfunction and improving fluid homeostasis with Elabela peptide hormone Daozhan Yu, Rongze Yang, Alan Shuldiner, Ling Chen 2019-11-05
8058014 Method of diagnosing or predicting disease states in a subject using omentin 1 and omentin 2 John McLenithan, Alan Shuldiner, Rong-Ze Yang 2011-11-15
7914985 Alanine transaminase enzymes and methods of use Alan Shuldiner, Rong-Ze Yang 2011-03-29
7550435 Method of modifying glucose activity using polypeptides selectively expressed in fat tissue John McLenithan, Alan Shuldiner, Rongze Yang 2009-06-23
7312197 Method of modifying glucose activity using polypeptides selectively expressed in fat tissue John McLenithan, Alan Shuldiner, Rongze Yang 2007-12-25